The PI3 K/AKT/mTOR (PAM) pathway has been implicated to play a pivotal role in BC progression via governing the maintenance of BCSCs and their EMT properties (Chang et al. 2013; Hong et al. 2024). This evidence concerns the gene AKT1 and breast cancer.